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Method: Retrospective study in two referral centres,
including all patients undergoing closure of interatrial
right-to-left shunt associated with hypoxaemia.
Results: Since 2001, 21 consecutive patients under-
went interventional shunt closure usingthe ‘‘Amplatzer
device’’; two patients had atrial septal defect and 19 had
patent foramen ovale. Three patients had minor adverse
events; two patients have a tiny residual shunt. Transcu-
taneous oxygen saturation and partial oxygen pressure
increased significantly from 86 ± 5 to 95 ± 3% (p < 0.001)
and from 49.8 ± 6.8 to 82.9 ± 30.4 mmHg (p = 0.001),
respectively. Seventeen (80%) patients reported clinical
improvement. However, patients with chronic respira-
tory insufficiency remained more symptomatic, with
three deaths after a median follow-up of 35 (6–97) months
and 89% remaining in New York Heart Association class
III/IV (vs 29% of patients without chronic respiratory
insufficiency; p = 0.035).
Conclusion: Hypoxaemic shunts are treated effec-
tively by transcatheter closure, resulting in functional
improvement in patients without respiratory insuffi-
ciency. When associated with chronic respiratory insuffi-
ciency, hypoxaemia often persists after shunt closure. In
such cases, the right-to-left atrial shunt does not seem to
be the main cause of hypoxaemiaand the indication for
closure is questionable.
http://dx.doi:10.1016/j.jsha.2013.03.124
Clinical outcome of familial hypercholesterolemia
(FH) at King Abdulaziz Medical City, Riyadh-A 20
year experience
Mohammad Alghamdi, Emad Aljohani
Familial Hypercholesterolemia (FH), is a well recog-
nized risk factor for premature atherosclerosis and
increased cardiovascular mortality. Prevalence of FH
and FHrelated cardiovascular adverse clinical outcomes
in the Saudi population are unknown.
The aim of this study is to evaluate; epidemiological
aspects, current management practices and clinical out-
comes of FH over a 20-year-period, in King Abdulaziz
medical city-Riyadh (KAMC-R).
This is a retrospective, chart review study that
includes patients of both genders and all ages, who have
been clinically diagnosed as FH or have had significantly
elevated cholesterol level, after excluding secondary
causes of hypercholesterolemia. Potential study candi-
dates between January 1990 and December 2010 were
identified through hospital information system and labo-
ratory database. Study population was limited to a sub-
group of patients who have an LDL-C P10 mmol/l as a
potential homozygous phenotype, representing the high-
est risk population who deserves special medical atten-
tion. A set of predetermined demographic, clinical and
laboratory variables were meticulously extracted from
paper charts and electronic medical records. Out of
1227 discharge diagnosis of FH and 29,196 laboratory
database candidates of LDL-C >4 mmol/l, 31 subjects
met the study criteria. All patients are Saudi Nationals
with mean age of 23 years and 52% being males. Xan-
thoma was documented in 87% with mean baseline
LDL-C of 16.5 mmol/l and latest available mean LDL-C
of 14 mmol/l. Statins were used in 94%, while longterm
apheresis therapy was performed for 2 individuals (7%)
and none of the study population underwent liver trans-
plantation. Ten (32%) patients with mean age of 21 years
underwent cardiac surgical interventions in form of
CABG, mostly in combination with different valve
replacement procedures. Seven patients (23%) were
either documented to be dead or lost to follow up.
The demographic distribution, clinical features and
laboratory parameters are highly suggestive of Homozy-
gous FH in the majority of study population. This large
number of potential Homozygous FH in a small Saudi
community is highly suggestive of increased prevalence
of FH in the Saudi population at large as compared to
the western countries. The reported adverse clinical out-
comes in conjunction with persistently elevated LDL-C
level may reflect the substandard lipid lowering strate-
gies being delivered to this population.
National FH registry and comprehensive FH manage-
ment program are strongly recommended for urgent
implementation.
http://dx.doi:10.1016/j.jsha.2013.03.125
Association of khat chewing with significant coro-
nary artery disease in patients presenting with
heart failure
Mohammed Al-Shami, Ahmed Al-Motarreb
Background: Khat has been associated with higher
rates of heart failure among patients presenting with
acute coronary syndrome (ACS). Coronary artery spasm
was the mechanism by which khat worked to induce
ACS in laboratory animal. In human; there is still lack
of data about this mechanism.
Objective: To evaluate the effect of khat chewing on
the coronary arteries in patients with history of heart fail-
ure using coronary arteriography (CAG).
Patients and methods: Cross sectional observa-
tional prospective study. All patients who underwent
CAG as elective one day procedure at Al-Thawra Modern
General Hospital, Cardiac Center, over the period from
April 2011 to August 2011 were included in our study.
Results: Out of total 365 patients, 109 (30%) had his-
tory of heart failure before CAG. The mean ± SD for the
age in years was 57.64 ± 9, with 66% male. Ischemic heart
disease was the cause of heart failure in 70 patients, 26
patients had valvular heart disease and 13 patients had
other causes of heart failure. History of khat chewers
was positive in 86 patients (79%). Khat chewers were
more likely to be men (79% vs. 17%) and had chest pain
in their presentation before CAG (70% vs. 43.5%)
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